4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001415889-25-002940
Chief Scientific Officer gave up 11,317 shares (to pay taxes)
- Chief Scientific Officer acquired 22,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Monahan Joseph Chief Scientific Officer | 2025-02-01 | Option exercise | +7,500 | 228,562 | D | ||
| Monahan Joseph Chief Scientific Officer | 2025-02-01 | Option exercise | +14,750 | 243,312 | D | ||
| Monahan Joseph Chief Scientific Officer | 2025-02-01 | Shares withheld for taxes | −11,317 | $2.48 | $28,066 | 231,995 | D |
| Derivatives | |||||||
| Monahan Joseph Chief Scientific Officer | 2025-02-01 | Option exercise · Restricted Stock Units | −7,500 | 15,000 | D | ||
| Monahan Joseph Chief Scientific Officer | 2025-02-01 | Option exercise · Restricted Stock Units | −14,750 | 44,250 | D | ||
| Monahan Joseph Chief Scientific Officer | 2025-02-03 | Grant or award · Restricted Stock Units | +83,900 | 83,900 | D | ||
| Monahan Joseph Chief Scientific Officer | 2025-02-03 | Grant or award · Employee Stock Option (Right to Buy) | +293,500 | 293,500 | D | ||
Loading xslF345X05/form4-02042025_040206.xml…